Menicon Co., Ltd.

7780.T
Medical Instruments & Supplies
2026/08/03 Updated
Market Cap: $815.0M (¥128.7B)
Stock Price: $10.98 (¥1,735)
Exchange Rate: 1 USD = ¥157.98

Notice on the Issuance Details of Stock-Compensation-Type Stock Options (New Share Options) for Our Executive Officers, Directors, and Employees, and Directors and Employees of Our Subsidiaries

Issuance details of stock options have been finalized. Specifies the total units allocated and the paid-in amount for the 34th to 37th allocations (or not required). For the 37th allocation, the number of recipients and allocation decreased from the initial disclosure. The resolutions were made on June 26, 2026, at the Annual General Meeting held on June 26, 2026, and the issuance resolution on the same date.

Importance:
Page Updated: August 3, 2026
IR Disclosure Date: August 3, 2026

Key Figures

  • Total number of stock options: 446 units (34th allocation)
  • Total number of stock options: 102 units (35th allocation)
  • Total number of stock options: 158 units (36th allocation)
  • Total number of stock options: 517 units (37th allocation)
  • Paid-in amount: 115,800 yen per unit (1,158.00 yen per share)

AI要約

Finalization of issuance details and overview

The finalized details for the stock-compensation-type stock option issuance announced today include the total numbers and paid-in amounts for stock options from the 34th through the 37th allocations. For the 34th allocation, a total of 446 units, paid-in amount of 115,800 yen per unit (1,158.00 yen per share), and recipients: 5 executives, 2 directors, and 16 employees. For the 35th allocation, a total of 102 units, paid-in amount the same. For the 36th allocation, a total of 158 units, with no monetary payment required. For the 37th allocation, a total of 517 units issued to 15 recipients, domestic and non-residents alike.

Shareholder, financial impact, and dates

The paid-in amount is not cash-paid due to offsetting against payable obligations and reward entitlement. The resolutions were adopted by the Board of Directors on June 26, 2026, and the Annual General Meeting on June 26, 2026. This announcement represents finalized information regarding stock-compensation-type stock options; direct cash outlays related to capital costs are unlikely, but dilution factors may arise.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Menicon Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →